Carlyle to have 20th exit in Japan, selling Sunsho Pharmaceutical

Carlyle to have 20th exit in Japan, selling Sunsho Pharmaceutical

Global investment firm Carlyle has agreed to sell its entire investment in Sunsho Pharmaceutical, a Japanese contract manufacturer of health and nutrition products, to Osaka-based Towa Pharmaceutical.

The financial details of the deal were not disclosed. Carlyle said in a statement that the transaction is expected to be completed in February next year.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter